发明名称 |
Derivado de imidazol, composição farmacêutica, métodos para a produção de um derivado de imidazol e de um composto oticamente ativo de um derivado de imidazol ou de um seu sal farmaceuticamente aceitável, composto, sal, e, sal diastereomérico |
摘要 |
The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumour such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like. |
申请公布号 |
BR0115306(B1) |
申请公布日期 |
2013.12.24 |
申请号 |
BR20010115306 |
申请日期 |
2001.11.16 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
AKIHIRO TASAKA;TAKONORI HITAKA;NOBUYUKI MATSUNAGA;MASAMI KUSAKA;MARI ADACHI;ISAO AOKI;AKIO OJIDA |
分类号 |
C07D233/62;C07D487/04;A61K31/165;A61K31/4174;A61K31/4188;A61K31/437;A61K45/00;A61P5/28;A61P35/00;A61P43/00;C07D233/54;C07D471/04 |
主分类号 |
C07D233/62 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|